A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...

2025 has come and gone. It was an interesting year and had its fair share of weird Vancouver stories. We’ve gone through some ...

This school year, all California State University students were given access to an educational version of ChatGPT, a ...

Researchers at Google have used their Willow quantum computer to demonstrate that "quantum contextuality" may be a crucial ...

Nvidia is kicking off 2026 with the early launch of its new Vera Rubin computing platform, following a record-breaking year ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Stewart Cheifet, the television producer and host who documented the personal computer revolution for nearly two decades on ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Nvidia just provided a closer look at its new computing platform for AI data centers, Vera Rubin, a release that could have major ramifications for the future of AI given the industry’s massive ...

And, as we changed this means of interaction rather quickly, one way we did it has to do with games. Game engines are now AI ...